Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Douty Bamba"'
Autor:
Rushit N. Lodaya, Amey P. Kanitkar, Asma Ashraf, Douty Bamba, Mansoor M. Amiji, Derek T. O’Hagan
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 238 (2023)
The development of new vaccine adjuvants represents a key approach to improvingi the immune responses to recombinant vaccine antigens. Emulsion adjuvants, such as AS03 and MF59, in combination with influenza vaccines, have allowed antigen dose sparin
Externí odkaz:
https://doaj.org/article/c0bf05fd78584559baf39398c77b6cd2
Autor:
Rushit N Lodaya, Amey P Kanitkar, Asma Ashraf, Douty Bamba, Mansoor M. Amiji, Derek T. O'Hagan
Research for novel vaccine adjuvants remains a critical need to improve the immune responses to a recombinant vaccine antigen. Emulsion adjuvants such as AS03 and MF59, particularly in the area of Influenza vaccines, have shown antigen dose sparing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd01b5f9f057b37bbef5cd4c41493d2d
https://doi.org/10.20944/preprints202211.0123.v1
https://doi.org/10.20944/preprints202211.0123.v1
Autor:
Alonso Heredia, Douty Bamba, Nhut Le, Bruce L. Gilliam, Robert C. Gallo, Robert R. Redfield, George K. Lewis, Robin Flinko, Anthony L. DeVico
Publikováno v:
AIDS. 21:1317-1322
Objective and design Studies in cell lines have demonstrated that CCR5 coreceptor levels influence the replication efficiency and Enfuvirtide (T-20) susceptibility of R5 HIV-1 strains. At present, however, the role that CCR5 levels on primary CD4 T c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac7eb20c33cd75f11d1294e6c2eb86d
https://doi.org/10.1097/qad.0b013e32815278ea
https://doi.org/10.1097/qad.0b013e32815278ea
Autor:
Muhammad Y Gwarzo, Mariola Sadowska, Nhut Le, Alonso Heredia, Charles B. Davis, Douty Bamba, Robert C. Gallo, Robert R. Redfield
Publikováno v:
AIDS. 19:2087-2095
OBJECTIVE To evaluate the effects of the cyclin dependent kinase (CDK) inhibitor Indirubin-3'-monoxime (IM) on Tat-mediated transactivation function, a step of the HIV-1 cycle that is not currently targeted in antiviral therapy. METHODS The effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8d7afbab9fb612a478a7055c0a98b8
https://doi.org/10.1097/01.aids.0000194805.74293.11
https://doi.org/10.1097/01.aids.0000194805.74293.11
Autor:
Aurelio Bonavia, Zena Fesseha, Douty Bamba, Leyla Diaz, Baoquan Sui, Ruben O Donis, Michael Goldblatt, Wu-Bo Li, Josephine Cassella, Michael S. Kinch, David Santos, Li-Mei Chen, Roxanne Duan
Publikováno v:
Virus Adaptation and Treatment.
Aurelio Bonavia1*, Leyla S Diaz1*, David Santos1, Josephine Cassella1, Zena Fesseha1, Douty Bamba1, Baoquan Sui1, Wu-Bo Li1, Roxanne Duan1, Li-Mei Chen2, Ruben O Donis2, Michael Goldblatt1, Michael S Kinch11Functional Genetics, Inc, Gaithersburg, MD,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3beb5805220eb24ccfd19389155ac300
https://www.dovepress.com/antibody-targeting-of-tsg101-on-influenza-infected-cells-peer-reviewed-article-VAAT
https://www.dovepress.com/antibody-targeting-of-tsg101-on-influenza-infected-cells-peer-reviewed-article-VAAT
Autor:
Nhut Le, C. David Pauza, Alonso Heredia, Douty Bamba, Robert R. Redfield, Bruce L. Gilliam, Joseph Bryant, Anthony L. DeVico
Publikováno v:
AIDS (London, England). 21(15)
G1 cytostatic drugs reduce CCR5 co-receptor expression and enhance the antiviral activity of a CCR5 antagonist in vitro. The administration of rapamycin, a G1 cytostatic agent, to three cynomolgous macaques led to decreased CCR5 messenger RNA express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c0f555146d076e45f64406acd8e8dc
https://pubmed.ncbi.nlm.nih.gov/17885304
https://pubmed.ncbi.nlm.nih.gov/17885304
Autor:
Gregory B. Melikyan, Bruce Gilliam, Olga Latinovic, Douty Bamba, Nhut Le, Alonso Heredia, Anthony L. DeVico, Robert R. Redfield, Robert C. Gallo
The CCR5 chemokine receptor plays a pivotal role in human immunodeficiency virus type 1 (HIV-1) infection. Several studies have suggested that CCR5 density levels in individuals are rate limiting for infection. In addition, CCR5 density levels influe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::533af7da27a70bd287960e4f52d241cb
https://europepmc.org/articles/PMC1913226/
https://europepmc.org/articles/PMC1913226/
Autor:
Anthony Amoroso, Robert R. Redfield, Charles E. L. B. Davis, Robert C. Gallo, Nhut Le, Alonso Heredia, Douty Bamba
Publikováno v:
Retrovirology, Vol 2, Iss Suppl 1, p P134 (2005)
The fusion inhibitor T20 marks the beginning of a new era in the management of HIV-1 disease. By inhibiting viral entry, T20 suppress viral replication in patients carrying strains resistant to reverse transcriptase or protease inhibitors. However, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19237b46ead5696c6538e10a7f1d12e2
https://doaj.org/article/edc7db2eb7c94fbf8850c02760993249
https://doaj.org/article/edc7db2eb7c94fbf8850c02760993249
Autor:
Greg Taylor, Robert R. Redfield, Charles E. L. B. Davis, Nhut Le, Alonso Heredia, Douty Bamba, Anthony Amoroso
Publikováno v:
AIDS (London, England). 19(8)
We evaluated the effect of vitamin E in controlling HIV-1 production upon activation of the patients' reservoir of resting CD4 lymphocytes in tissue culture experiments. The addition of vitamin E to patients' cultures resulted in significantly reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0ad0e845814ed5127750d0b9b752ec
https://pubmed.ncbi.nlm.nih.gov/15867501
https://pubmed.ncbi.nlm.nih.gov/15867501
The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza
Autor:
Shaojing Chang, Michael Goldblatt, Douty Bamba, Wu-Bo Li, Roxanne Duan, Baoquan Sui, Huong Ung, Jessica Van Dyke, Michael S. Kinch, Ke Weng
Publikováno v:
Virology. (2):473-481
Conventional approaches for therapeutic targeting of viral pathogens have consistently faced obstacles arising from the development of resistant strains and a lack of broad-spectrum application. Influenza represents a particularly problematic therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a22547a8245a9caf0fa0561742f889